Rapidly progressive glomerulonephritis: current and evolving treatment strategies
Little, M.A.; Pusey, C.D.
Journal of Nephrology 17(Suppl): S10-S19
2004
ISSN/ISBN: 1121-8428 PMID: 15599880 Document Number: 568959
Rapidly progressive glomerulonephiritis (RPGN) must be diagnosed and treated quickly to prevent irreversible organ injury. The commonest cause of RPGN is anti-neutrophil cytoplasm antibody (ANCA) associated small vessel vasculitis, and the most severe is anti-glomerular basement membrane (GBM) antibody disease. In this review we address pathogenesis, diagnosis, treatment and outcome in these two entities, with emphasis on novel therapies.